Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data
2025 · Expert Review of Endocrinology & Metabolism · 6 citations
https://doi.org/10.1080/17446651.2025.2459720